Bony metastases from breast cancer: a study of foetal antigen 2 as a blood tumour marker.

Cheung, Kwok-Leung and Iles, Ray K. and Robertson, John (2010) Bony metastases from breast cancer: a study of foetal antigen 2 as a blood tumour marker. World Journal of Surgical Oncology, 8 (38). ISSN 1477-7819

[img]
Preview
PDF
Download (76kB)
This item is available in: Library Catalogue

Abstract

Background : Foetal antigen 2 (FA-2), first isolated in the amniotic fluid, was shown to be the circulating form of the aminopropeptide of the alpha 1 chain of procollagen type I. Serum concentrations of FA-2 appeared to be elevated in a number of disorders of bone metabolism. This paper is the first report of its role as a marker of bone metabolism in metastatic breast cancer.
Methods: Serum FA-2 concentrations were measured by radioimmunoassay in 153 women with different stages of breast cancer and in 34 normal controls.
Results: Serum FA-2 was significantly elevated in women with bony metastases (p < 0.015). Its levels were not significantly different among women with non-bony metastases, with non-metastatic disease, as well as among normal controls.
Conclusions: FA-2 is a promising blood marker of bone metabolism. Further studies to delineate its role in the diagnosis and management of bony metastases from breast cancer are required.

Item Type: Article
Research Areas: A. > School of Science and Technology > Natural Sciences
ISI Impact: 0
Item ID: 6069
Notes on copyright: open access item
Useful Links:
Depositing User: Users 36 not found.
Date Deposited: 10 Jun 2010 14:44
Last Modified: 16 Dec 2015 16:29
URI: http://eprints.mdx.ac.uk/id/eprint/6069

Actions (login required)

Edit Item Edit Item

Full text downloads (NB count will be zero if no full text documents are attached to the record)

Downloads per month over the past year